NESS ZIONA, Israel (April 28, 2015) – Kamada Ltd. (Nasdaq and TASE: KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces executive management changes intended to strengthen the Company's leadership while benefitting from its accomplished executives and advancing its protein therapeutics platform. Under the changes, David Tsur, co-founder and Chief Executive Officer, will […]
Demonstrates efficacy in a variety of lung function measurements based on post hoc statistical analyses as recommended by EMA
NESS ZIONA, Israel (April 1, 2015) – Kamada Ltd. (Nasdaq and TASE: KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces that the Company has received an allowance from the Canadian Intellectual Property Office (CIPO) for Patent Application No. 2,538,998 entitled, “Large Scale Preparation of Alpha-1 Proteinase Inhibitor and Use Thereof.” The allowed […]
NESS ZIONA, Israel (March 23, 2015) – Kamada Ltd. (Nasdaq and TASE: KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces that the European Commission, acting on the recommendation from the Committee for Orphan Medicinal Products of the European Medicines Agency (EMA), has designated the Company's proprietary human intrevenous (IV) Alpha-1 Antitrypsin (AAT) […]
Experienced industry executive enhances medical knowledge and capability
Posts Record Revenue for the Fourth Quarter and Generates Net Profit
Conference call begins today at 8:30 a.m. Eastern time
Conference call to report Fourth Quarter and Year End 2014 financial results scheduled for February 11, 2015
Majority of patients who continued treatment with AAT maintained capability of insulin secretion and attained glycemic targets with HbA1C level below 7.5% for more than 2 years after diagnosis of type 1 diabetes
Expects to report results from its Anti-Rabies Immunoglobulin U.S. Phase II/III clinical trial in the first half of 2015
Results support publication of pre-clinical data in Blood in September